-
NMPA Issued the Administrative Measures for Drug Quality Sampling Inspection
2019-08-19
NMPA issued the Administrative Measures for Drug Quality Sampling Inspection,effective as of the date of promulgation.
-
NMPA Issued the Notice on Enabling the New Version of the Drug Production License and other Certificates
2019-08-07
To standardize the formats and renewal of the drug administrative licenses, on August 7, 2019, NMPA issued the Notice on Enabling the New Version of the Drug Production License and other Certificates,and notified the relevant matters as follows.
-
NMPA, Ministry of Public Security, National Health Commission issued the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances
2019-08-06
NMPA,the Ministry of Public Security, and the National Health Commission decided to include oxycodone containing compound preparations in the management of psychotropic substances.
-
NMPA Issued the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs
2019-08-02
NMPA issued the Announcement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs.
-
NMPA Issued the Notice on Expanding the Pilot of the Medical Device Registrant System
2019-08-01
NMPA issued the Notice on Expanding the Pilot of the Medical Device Registrant System (NMPA Department for Medical Device Registration [2019] No. 33.